Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trialPerry B. Shieh, Salvador Rico, Nancy L. Kuntz et al.|The Lancet Neurology|2023Cited by 120
Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the diseaseChristian Lechner, Kevin Rostásy, Steffen Leiz et al.|Journal of Neurology Neurosurgery & Psychiatry|2015Cited by 117
Oligoclonal bands predict multiple sclerosis in children with optic neuritisNicole Heußinger, Mathias Buttmann, Evangelos Kontopantelis et al.|Annals of Neurology|2015Cited by 76